🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a double-blind, randomized, placebo- and positive-controlled, para...
Status
Completed
Location
Parexel Early Phase Clinical Unit (Los Angeles)
Start Date
2021-08-05
Trial ID
NCT05046132
Treatments Being Tested
This was a single-center, multiple-dose, randomized, double-blind, placebo-...
Status
Completed
Location
PRA International Clinical Pharmacology Center (EDS US Clinic)
Start Date
2019-02-07
Trial ID
NCT03808298
Treatments Being Tested
The purpose of the study is to evaluate the effects of clinical and high cl...
Status
Completed
Location
ICON Lenexa
Start Date
2023-04-12
Trial ID
NCT05818852
Treatments Being Tested
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT01787357
Treatments Being Tested
This is a single-center, double-blind, randomized, placebo- and positive-co...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2012-06
Trial ID
NCT02206204
Treatments Being Tested
The purpose of this study is: * to evaluate if E4 has any effect on how th...
Status
Completed
Location
QPS Miami
Start Date
2021-03-09
Trial ID
NCT04819906
Treatments Being Tested
The present study has been designed to evaluate the effect of three doses o...
Status
Completed
Location
CROSS Research S.A., Phase I Unit,
Start Date
2017-03-20
Trial ID
NCT03516630
Treatments Being Tested
This study is designed to evaluate the effect of multiple doses of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01910415
Treatments Being Tested
To determine if a single subcutaneous (SC) administration of TTX at various...
Status
Completed
Location
Celerion
Start Date
2018-02-07
Trial ID
NCT04083833
Treatments Being Tested
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested